Nutrition and cognitive impairment in the elderly

As the number of older people is growing rapidly worldwide and the fact that elderly people are also apparently living longer, dementia, the most common cause of cognitive impairment is getting to be a greater public health problem. Nutrition plays a role in the ageing process, but there is still a lack of knowledge about nutrition-related risk factors in cognitive impairment. Research in this area has been intensive during the last decade, and results indicate that subclinical deficiency in essential nutrients (antioxidants such as vitamins C, E and β-carotene, vitamin B12, vitamin B6, folate) and nutrition-related disorders, as hypercholesterolaemia, hypertriacylglycerolaemia, hypertension, and diabetes could be some of the nutrition-related risk factors, which can be present for a long time before cognitive impairment becomes evident. Large-scale clinical trials in high-risk populations are needed to determine whether lowering blood homocysteine levels reduces the risk of cognitive impairment and may delay the clinical onset of dementia and perhaps of Alzheimer's disease. A curative treatment of cognitive impairment, especially Alzheimer's disease, is currently impossible. Actual drug therapy, if started early enough, may slow down the progression of the disease. Longitudinal studies are required in order to establish the possible link of nutrient intake – nutritional status with cognitive impairment, and if it is possible, in fact, to inhibit or delay the onset of dementia.

[1]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[2]  J. Thome,et al.  Free radicals in Alzheimer's dementia: currently available therapeutic strategies. , 1998, Journal of neural transmission. Supplementum.

[3]  Y. Stern,et al.  Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. , 1993, Archives of neurology.

[4]  Pascale Barberger-Gateau,et al.  Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study , 2000, Neuroepidemiology.

[5]  R. Cumming,et al.  Cohort study of vitamin C intake and cognitive impairment. , 1998, American journal of epidemiology.

[6]  L. Schneider New therapeutic approaches to cognitive impairment. , 1998, The Journal of clinical psychiatry.

[7]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[8]  S. Maxwell,et al.  Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia , 1998, International journal of geriatric psychiatry.

[9]  S. Birge Hormones and the aging brain. , 1998, Geriatrics.

[10]  J. Bachevalier,et al.  Folate-responsive neurological and mental disorders: report of 16 cases. Neuropsychological correlates of computerized transaxial tomography and radionuclide cisternography in folic acid deficiencies. , 1977, European neurology.

[11]  K. Pietrzik,et al.  Lowering of homocysteine concentrations in elderly men and women. , 1999, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[12]  R. Baumgartner,et al.  Folate nutrition and older adults: challenges and opportunities. , 1997, Journal of the American Dietetic Association.

[13]  Swain Ra An update of vitamin B12 metabolism and deficiency states. , 1995 .

[14]  P. Galan,et al.  Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX. , 1997, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[15]  M. Hennerici,et al.  Homocysteine in cerebral macroangiography and microangiopathy , 1999, The Lancet.

[16]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[17]  J. Goodwin,et al.  Association between nutritional status and cognitive functioning in a healthy elderly population. , 1983, JAMA.

[18]  B. Winblad,et al.  Cobalamin Levels Are Not Reduced in Alzheimer's Disease: Results from a Population‐Based Study , 1994, Journal of the American Geriatrics Society.

[19]  L. Beckett,et al.  Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[20]  H. Venters,et al.  Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation 1 An abstract of some of these findings was published in Mol. Biol. Cell, 7:S (1996) #3765. 1 , 1997, Brain Research.

[21]  M. Elias Effects of chronic hypertension on cognitive functioning. , 1998, Geriatrics.

[22]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[23]  E. Lesaffre,et al.  Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  M. Rodo,et al.  Apolipoprotein E Genotype and Lipid and Lipoprotein Levels in Dementia , 2000, Dementia and Geriatric Cognitive Disorders.

[25]  F. Rodríguez‐Artalejo,et al.  Value of Hodkinson's test for detecting dementia and mild cognitive impairment in epidemiological surveys. , 1994, Neuroepidemiology.

[26]  G. López,et al.  Age-associated changes in the content and fatty acid composition of brain glycerophospholipids. , 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[27]  F. Panza,et al.  High monounsaturated fatty acids intake protects against age-related cognitive decline , 1999, Neurology.

[28]  C. Behl Vitamin E and other antioxidants in neuroprotection. , 1999, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[29]  R. Ihl,et al.  Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. , 1997, Journal of psychiatric research.

[30]  L. Oreland,et al.  Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders , 1995, European Neuropsychopharmacology.

[31]  D. B. Wilson,et al.  Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. , 1999, The American journal of clinical nutrition.

[32]  M. Orrell,et al.  Antioxidants and dementia , 1997, The Lancet.

[33]  N. Wellman,et al.  Position of the American Dietetic Association: nutrition, aging, and the continuum of care. , 1996, Journal of the American Dietetic Association.

[34]  K. Blennow,et al.  The Role of the Polymorphic Genes Apolipoprotein E and Methylene- tetrahydrofolate Reductase in the Development of Dementia of the Alzheimer Type , 1999, Dementia and Geriatric Cognitive Disorders.

[35]  M. Bahro,et al.  Oestrogens and Alzheimer's disease , 2000, International Journal of Geriatric Psychiatry.

[36]  O. Rafaelsen,et al.  Vitamin B12 concentrations in psychiatric patients , 1979, Acta psychiatrica Scandinavica.

[37]  E. Feskens,et al.  Dietary patterns and cognitive function in elderly men in Finland, Italy and the Netherlands , 1998, European Journal of Clinical Nutrition.

[38]  Personality and psychopathology in late life. , 1998, Geriatrics.

[39]  P. Doraiswamy,et al.  Current Status of Antioxidant Therapy for Alzheimer's Disease , 1998, Journal of the American Geriatrics Society.

[40]  W M Tierney,et al.  Documentation and Evaluation of Cognitive Impairment in Elderly Primary Care Patients , 1995, Annals of Internal Medicine.

[41]  P. Doraiswamy,et al.  Combination Therapy for Early Alzheimer's Disease: What Are We Waiting for? , 1998, Journal of the American Geriatrics Society.

[42]  D. Selkoe,et al.  Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.

[43]  N. Bornstein,et al.  ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. , 1998, Stroke.

[44]  K. Pietrzik,et al.  Folate in preventive medicine: a new role in cardiovascular disease, neural tube defects and cancer. , 1997, Annals of nutrition & metabolism.

[45]  F. Holsboer,et al.  [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection]. , 1998, Fortschritte der Neurologie-Psychiatrie.

[46]  T. Bottiglieri Folate, vitamin B12, and neuropsychiatric disorders. , 2009, Nutrition reviews.

[47]  M. Pahor,et al.  Factors Associated with Cognitive Impairment Among Older Italian Inpatients , 1997, Journal of the American Geriatrics Society.

[48]  Peter E. Hilsenrath,et al.  The World Health Report 2000 , 2002 .

[49]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[50]  R. Lappalainen,et al.  Association of sociodemographic factors with barriers reported by patients receiving nutrition counseling as part of cardiac rehabilitation. , 1998, Journal of the American Dietetic Association.

[51]  A. McCaddon,et al.  Total serum homocysteine in senile dementia of Alzheimer type , 1998, International journal of geriatric psychiatry.

[52]  S. Roberts,et al.  Assessing problem feeding behaviors in mid-stage Alzheimer's disease. , 1996, Geriatric nursing.

[53]  S. Lovestone,et al.  The association between APOE and dementia does not seem to be mediated by vascular factors , 2000, Neurology.

[54]  R. Wurtman,et al.  Brain serotonin content: physiological regulation by plasma neutral amino acids. , 1997, Science.

[55]  M. Ramirez-Lassepas Stroke and the aging of the brain and the arteries. , 1998, Geriatrics.

[56]  J W Miller,et al.  Nutritional factors in physical and cognitive functions of elderly people. , 1992, The American journal of clinical nutrition.

[57]  R. Chandra,et al.  Graying of the immune system. Can nutrient supplements improve immunity in the elderly? , 1997, JAMA.

[58]  E. Berry,et al.  Refusal to eat in the elderly. , 2009, Nutrition reviews.

[59]  J. Stephenson World health report. , 2004, Lancet.

[60]  D. Knopman,et al.  Current pharmacotherapies for Alzheimer's disease. , 1998, Geriatrics.

[61]  A. Lindgren,et al.  Hyperhomocysteinaemia—a common finding in a psychogeriatric population , 1996, European journal of clinical investigation.

[62]  M. Koivusalo,et al.  The World Health Report 2000 , 2002 .

[63]  R. Ihl,et al.  A Comparison of ADAS and EEG in the Discrimination of Patients with Dementia of the Alzheimer Type from Healthy Controls , 2000, Neuropsychobiology.

[64]  A. Hofman,et al.  Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. , 1996, American journal of epidemiology.

[65]  F. van Harskamp,et al.  Abnormal amino acid metabolism in patients with early stage Alzheimer dementia , 1998, Journal of Neural Transmission.

[66]  I. Bell,et al.  Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people , 1992, Acta psychiatrica Scandinavica.

[67]  A. Norberg,et al.  Eating problems in severely demented patients. Issues and ethical dilemmas. , 1989, The Nursing clinics of North America.

[68]  G. Jensen,et al.  Nutrition of the Elderly , 1971 .

[69]  R. Schmidt,et al.  Plasma Antioxidants and Cognitive Performance in Middle‐Aged and Older Adults: Results of the Austrian Stroke Prevention Study , 1998, Journal of the American Geriatrics Society.

[70]  G. Fraser,et al.  Variables associated with cognitive function in elderly California Seventh-day Adventists. , 1996, American journal of epidemiology.

[71]  C. Gottfries,et al.  Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease , 1998, Journal of Neural Transmission.

[72]  S. Birge The role of estrogen in the treatment and prevention of dementia: introduction. , 1997, The American journal of medicine.

[73]  C. Brayne,et al.  Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. , 1997, American journal of medical genetics.

[74]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[75]  W. Simonson Promising agents for treating Alzheimer's disease. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[76]  L. Parnetti,et al.  Role of homocysteine in age-related vascular and non-vascular diseases , 1997, Aging.

[77]  B. Vellas,et al.  Low plasma vitamin C in Alzheimer patients despite an adequate diet , 1998, International journal of geriatric psychiatry.

[78]  R. Doty Olfactory Capacities in Aging and Alzheimer's Disease a , 1991 .

[79]  J. Frank,et al.  Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to the muscarinic receptor , 1996, Brain Research.

[80]  L. Launer Overview of incidence studies of dementia conducted in Europe. , 1992, Neuroepidemiology.

[81]  F. Holsboer,et al.  Oxidativer Streß in der Pathogenese von Morbus Alzheimer und antioxidative Neuroprotektion , 1998 .

[82]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[83]  R. Swain An update of vitamin B12 metabolism and deficiency states. , 1995, The Journal of family practice.

[84]  J. Biederman,et al.  Attention-deficit/hyperactivity disorder: a life-span perspective. , 1998, The Journal of clinical psychiatry.

[85]  C. Martyn,et al.  Cognitive impairment and mortality in a cohort of elderly people , 1996, BMJ.

[86]  I. Young,et al.  Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. , 1999, QJM : monthly journal of the Association of Physicians.

[87]  M. Ferry,et al.  Mental health: minimental state examination and geriatric depression score of elderly Europeans in the SENECA study of 1993. , 1996, European journal of clinical nutrition.

[88]  T. Lancaster,et al.  The new NHS: Medical students say no , 1998 .

[89]  W. Reid,et al.  ECT in Texas: 19 months of mandatory reporting. , 1998, The Journal of clinical psychiatry.

[90]  J. Morris,et al.  Current concepts in the pathogenesis of Alzheimer's disease. , 1997, The American journal of medicine.

[91]  E. Feskens,et al.  Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.

[92]  J. Galen Buckwalter,et al.  The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities , 1995, European journal of haematology.

[93]  F. Jessen,et al.  Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. , 2000, Journal of lipid research.

[94]  R. Mayeux,et al.  Low-density lipoprotein cholesterol and the risk of dementia with stroke. , 1999, JAMA.

[95]  R. Doty Olfactory capacities in aging and Alzheimer's disease. Psychophysical and anatomic considerations. , 1991, Annals of the New York Academy of Sciences.

[96]  W. Markesbery,et al.  Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. , 2000, The American journal of clinical nutrition.

[97]  A. Spiro,et al.  Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.